As of 8:07:05 AM GMT+2. Market Open.

OKN-007 is being evaluated both alone and in combination with chemotherapy for patients with glioma or glioblastoma — both types of brain cancer. Patients can now enroll in a phase 1 clinical trial ...

PRINCETON, NJ, and OKLAHOMA CITY, OK--(Marketwired - February 15, 2016) - GtreeBNT Co., Ltd., has entered into an agreement with the Oklahoma Medical Research Foundation (OMRF) to acquire the rights ...

Clinical outcomes of the combination of bevacizumab and ttfields in patients with recurrent glioblastoma: Results of a phase II clinical trial. This is an ASCO Meeting Abstract from the 2020 ASCO ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

At close: 29 May at 9:39:03 pm GMT+2 ...

At close: 18 June at 8:35:02 am GMT+2 ...